Answers are grounded in this paper and cite their sources.
Synovial Fluid-Derived Stem Cells (SFSCs) have emerged as a promising source of mesenchymal stem cells, offering a minimally invasive way of obtaining cells with high proliferative capacity and robust multilineage differentiation potential. Originating from the synovial membrane, SFSCs are believed to retain a cellular bias towards musculoskeletal tissue repair, positioning them as a valuable tool in treating musculoskeletal injuries and morbidities. Objective: To portray SFSCs differentiation behavior at early passage (P2) by evaluating their growth dynamics, immunophenotypic profile, and ability to differentiate into multilineages. Methods: In this experimental study, a typical MSC-like proliferation pattern was seen with distinct phases of lag, exponential and plateau growth curve. Immunohistochemistry revealed that CD73+, CD90+, and CD105+ lacking hematopoietic markers, further validated their MSC like nature. Results: SFSC showed bi-lineage differentiation into adipocytes and osteocytes validated by Oil O Red and Alizarin Red S staining respectively. Conclusions: In conclusion SFSC’s possesses regenerative potential, which could be a future of regenerative medicine to repair bones and soft tissues. These findings contribute to MSC biology and its implementation as therapeutic role via SFSCs in musculoskeletal disorders.
No takes yet. Share an insight, caveat, or question.
Sharif et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: